Literature DB >> 10349875

Role of conserved serine residues in the interaction of agonists with D3 dopamine receptors.

N Sartania1, P G Strange.   

Abstract

To understand the role of conserved serine residues in the fifth transmembrane domain (Ser192, Ser193, and Ser196) of the D3 dopamine receptor, these have been mutated individually to alanine, and the ligand binding properties of the mutant receptors have been evaluated. The mutations had little or no effect on the binding of the antagonist spiperone and the agonist quinpirole, indicating that the overall conformation of the receptor was unaffected. The binding of dopamine and 7-hydroxydipropylaminotetralin, agonists containing hydroxyl groups, was, however, of lower affinity for the Ser192 mutation but unaffected by the other mutations (Ser193 and Ser196). Therefore, for the agonists tested, the hydroxyl groups interact exclusively with Ser192.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10349875     DOI: 10.1046/j.1471-4159.1999.0722621.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  13 in total

1.  Investigation of various N-heterocyclic substituted piperazine versions of 5/7-{[2-(4-aryl-piperazin-1-yl)-ethyl]-propyl-amino}-5,6,7,8-tetrahydro-naphthalen-2-ol: effect on affinity and selectivity for dopamine D3 receptor.

Authors:  Dennis A Brown; Manoj Mishra; Suhong Zhang; Swati Biswas; Ingrid Parrington; Tamara Antonio; Maarten E A Reith; Aloke K Dutta
Journal:  Bioorg Med Chem       Date:  2009-04-19       Impact factor: 3.641

2.  Structurally constrained hybrid derivatives containing octahydrobenzo[g or f]quinoline moieties for dopamine D2 and D3 receptors: binding characterization at D2/D3 receptors and elucidation of a pharmacophore model.

Authors:  Dennis A Brown; Prashant S Kharkar; Ingrid Parrington; Maarten E A Reith; Aloke K Dutta
Journal:  J Med Chem       Date:  2008-12-25       Impact factor: 7.446

3.  A structural chemogenomics analysis of aminergic GPCRs: lessons for histamine receptor ligand design.

Authors:  A J Kooistra; S Kuhne; I J P de Esch; R Leurs; C de Graaf
Journal:  Br J Pharmacol       Date:  2013-09       Impact factor: 8.739

4.  Modification of agonist binding moiety in hybrid derivative 5/7-{[2-(4-aryl-piperazin-1-yl)-ethyl]-propyl-amino}-5,6,7,8-tetrahydro-naphthalen-1-ol/-2-amino versions: impact on functional activity and selectivity for dopamine D2/D3 receptors.

Authors:  Bhaskar Gopishetty; Suhong Zhang; Prashant S Kharkar; Tamara Antonio; Maarten Reith; Aloke K Dutta
Journal:  Bioorg Med Chem       Date:  2013-04-01       Impact factor: 3.641

5.  Homology Model Versus X-ray Structure in Receptor-based Drug Design: A Retrospective Analysis with the Dopamine D3 Receptor.

Authors:  Nicolas Levoin; Thierry Calmels; Stéphane Krief; Denis Danvy; Isabelle Berrebi-Bertrand; Jeanne-Marie Lecomte; Jean-Charles Schwartz; Marc Capet
Journal:  ACS Med Chem Lett       Date:  2011-02-11       Impact factor: 4.345

6.  Transmembrane segment five serines of the D4 dopamine receptor uniquely influence the interactions of dopamine, norepinephrine, and Ro10-4548.

Authors:  David F Cummings; Spencer S Ericksen; Angela Goetz; John A Schetz
Journal:  J Pharmacol Exp Ther       Date:  2010-03-09       Impact factor: 4.030

7.  Interaction of novel hybrid compounds with the D3 dopamine receptor: Site-directed mutagenesis and homology modeling studies.

Authors:  Sandhya Kortagere; Shu-Yuan Cheng; Tamara Antonio; Juan Zhen; Maarten E A Reith; Aloke K Dutta
Journal:  Biochem Pharmacol       Date:  2010-09-15       Impact factor: 5.858

8.  Further delineation of hydrophobic binding sites in dopamine D(2)/D(3) receptors for N-4 substituents on the piperazine ring of the hybrid template 5/7-{[2-(4-aryl-piperazin-1-yl)-ethyl]-propyl-amino}-5,6,7,8-tetrahydro-naphthalen-2-ol.

Authors:  Balaram Ghosh; Tamara Antonio; Bhaskar Gopishetty; Maarten Reith; Aloke Dutta
Journal:  Bioorg Med Chem       Date:  2010-06-12       Impact factor: 3.641

9.  Molecular Determinants of the Intrinsic Efficacy of the Antipsychotic Aripiprazole.

Authors:  Carmen Klein Herenbrink; Ravi Verma; Herman D Lim; Anitha Kopinathan; Alastair Keen; Jeremy Shonberg; Christopher J Draper-Joyce; Peter J Scammells; Arthur Christopoulos; Jonathan A Javitch; Ben Capuano; Lei Shi; J Robert Lane
Journal:  ACS Chem Biol       Date:  2019-08-05       Impact factor: 5.100

10.  Understanding the Structural Requirements of Hybrid (S)-6-((2-(4-Phenylpiperazin-1-yl)ethyl)(propyl)amino)-5,6,7,8-tetrahydronaphthalen-1-ol and its Analogs as D2/D3 Receptor Ligands: A Three-Dimensional Quantitative Structure-Activity Relationship (3D QSAR) Investigation.

Authors:  Gyan Modi; Horrick Sharma; Prashant S Kharkar; Aloke K Dutta
Journal:  Medchemcomm       Date:  2014-09-01       Impact factor: 3.597

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.